Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Nearly 30 years of experience in the Korean/Asian equity research. Major sectors coverage include the following:
- Technology 
- Consumer 
- Special Situations/Deep Value Plays
- Tender Offers/M&As
- Holdcos/Stubs
- Asian Unicorns/Private Companies

Korea/Asia, Events, IPOs

SKC: Plans to Issue EB Worth 125 Billion Won

SK Inc: Selling 1.25 Trillion Won Worth of SK Biopharm Through a PRS Contract

SKC: Aggressive Plans to Expand Rechargeable Battery & Semiconductor Materials - But At What Price?

Korean National Assembly FINALLY Passes the Bill for Mandatory Cancellation of Treasury Shares

Mandatory Cancellation of Treasury Shares: Final Approval by the Korean National Assembly on 24 Feb?

Douglas Research Advisory

Event-Driven

<ul>
<li>SKC Co announced a rights offering capital raise of 1 trillion won (US$700 million) to invest in new businesses (such as glass substrates) and improve its balance sheet.</li>
<li>SK Inc, the controlling shareholder of SKC with a 40.6% stake, agreed to participate in this rights offering with an oversubscription (120% of allocated shares).</li>
<li>Number of shares for the rights offering is 11.73 million shares. Expected dilution ratio is 23.6%. Expected rights offering price is 85,300 won which is 24% lower than current price.</li>
</ul>


SKC Co announced a rights offering capital raise of 1 trillion won (US$700 million) to invest in new businesses (such as glass substrates) and improve its balance sheet.
SK Inc, the controlling shareholder of SKC with a 40.6% stake, agreed to participate in this rights offering with an oversubscription (120% of allocated shares).
Number of shares for the rights offering is 11.73 million shares. Expected dilution ratio is 23.6%. Expected rights offering price is 85,300 won which is 24% lower than current price.


SKC Co Ltd

SKC: Rights Offering of 1 Trillion Won